Fibrosis and alcohol-related liver disease

被引:192
|
作者
Lackner, Carolin [1 ]
Tiniakos, Dina [2 ,3 ]
机构
[1] Med Univ Graz, Inst Pathol, Neue Stiftingtalstr 6, A-8010 Graz, Austria
[2] Newcastle Univ, Inst Cellular Med, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Univ Athens, Dept Pathol, Aretaie Hosp, Sch Med, Vas Sofias Ave 76, Athens 11528, Greece
基金
欧盟地平线“2020”;
关键词
Alcohol-related liver disease; Non-alcoholic fatty liver disease; Fibrosis; Histological staging; Regression; Pathogenesis; HEPATIC STELLATE CELLS; COLLAGEN PROPORTIONATE AREA; LONG-TERM PROGNOSIS; FATTY LIVER; SCORING SYSTEM; NONALCOHOLIC STEATOHEPATITIS; PERIVENULAR FIBROSIS; HISTOLOGIC FEATURES; STAGING SYSTEM; INCREASED RISK;
D O I
10.1016/j.jhep.2018.12.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Histological fibrosis stage is one of the most important prognostic factors in compensated and decompensated alcohol-related liver disease (ALD). Morphological assessment of fibrosis is useful for patient stratification, enabling individualised management, and for evaluation of treatment effects in clinical studies. In contrast to most chronic liver diseases where fibrosis is portal-based, fatty liver disease (FLD) of alcoholic or non-alcoholic aetiology (NAFLD) is associated with a centrilobular pattern of injury which leads to perivenular fibrosis and/or pericellular fibrosis. Progression of FLD drives expansive pericellular fibrosis, linking vascular structures and paving the way for the development of cirrhosis. At the cirrhotic stage, ongoing tissue damage leads to increasing fibrosis severity due to parenchymal loss and proliferation of fibrous scars. Histologic fibrosis staging systems have been devised, based on topography and the extent of fibrosis, for most chronic liver diseases. The utility of histological staging is reflected in different risks associated with individual fibrosis stages which cannot be reliably distinguished by non-invasive fibrosis assessment. In contrast to NAFLD, ALD-specific staging systems that enable the standardised prognostication required for clinical management and trials are lacking. Although morphological similarities between NAFLD and ALD exist, differences in clinical and histological features may substantially limit the utility of established NAFLD-specific staging systems for prognostication in ALD. This review summarises morphological features of fibrosis in ALD and compares them to other chronic liver diseases, particularly NAFLD. ALD-related fibrosis is examined in the context of pathogenetic mechanisms of fibrosis progression, regression and clinical settings that need to be considered in future prognostically relevant ALD staging approaches. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:294 / 304
页数:11
相关论文
共 50 条
  • [1] Liver Transplantation in Alcohol-related Liver Disease and Alcohol-related Hepatitis
    Wandji, Line Carolle Ntandja
    Ningarhari, Massih
    Lassailly, Guillaume
    Dharancy, Sebastien
    Boleslawski, Emmanuel
    Mathurin, Philippe
    Louvet, Alexandre
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (01) : 127 - 138
  • [2] Alcohol-related liver disease
    Testino, Gianni
    Caputo, Fabio
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (02) : 347 - 351
  • [3] Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
    Thiele, Maja
    Suvitaival, Tommi
    Trost, Kajetan
    Kim, Min
    de Zawadzki, Andressa
    Kjaergaard, Maria
    Rasmussen, Ditlev Nytoft
    Lindvig, Katrine Prier
    Israelsen, Mads
    Detlefsen, Sonke
    Andersen, Peter
    Juel, Helene Baek
    Nielsen, Trine
    Georgiou, Stella
    Filippa, Vicky
    Kuhn, Michael
    Nishijima, Suguru
    Moitinho-Silva, Lucas
    Rossing, Peter
    Trebicka, Jonel
    Anastasiadou, Ema
    Bork, Peer
    Hansen, Torben
    Legido-Quigley, Cristina
    Krag, Aleksander
    GASTROENTEROLOGY, 2023, 164 (07) : 1248 - 1260
  • [4] Prognostic models in alcohol-related liver disease and alcohol-related hepatitis
    Musto, Jessica Ann
    Lucey, Michael Ronan
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2023, 67
  • [5] Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease Authors' reply
    Israelsen, Mads
    Torp, Nikolaj
    Johansen, Stine
    Thiele, Maja
    Krag, Aleksander
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 604 - 604
  • [6] Liver Transplantation for Alcohol-Related Liver Disease
    Choudhary, Narendra S.
    Kumar, Naveen
    Saigal, Sanjiv
    Rai, Rahul
    Saraf, Neeraj
    Soin, Arvinder S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2016, 6 (01) : 47 - 53
  • [7] Sepsis in alcohol-related liver disease
    Gustot, Thierry
    Fernandez, Javier
    Szabo, Gyongyi
    Albillos, Agustin
    Louvet, Alexandre
    Jalan, Rajiv
    Moreau, Richard
    Moreno, Christophe
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 1031 - 1050
  • [8] Nutrition in Alcohol-Related Liver Disease
    Ayala-Valverde M.
    Arnold J.
    Díaz L.A.
    Idalsoaga F.
    Arrese M.
    Arab J.P.
    Current Hepatology Reports, 2022, 21 (4) : 111 - 119
  • [9] ALCOHOL-RELATED LIVER-DISEASE
    SHERLOCK, S
    BRITISH MEDICAL BULLETIN, 1982, 38 (01) : 67 - 70
  • [10] Recommendations for alcohol-related liver disease
    Bathgate, AJ
    LANCET, 2006, 367 (9528): : 2045 - 2046